By Nancy LapidOct 30 (Reuters) - Today we report on a troubling cancer trend among US adults of all ages. We also report on impressive survival data from a two-drug regimen
By Nancy LapidOct 28 (Reuters) - With wildfires becoming larger and more prevalent, today we report on a study that suggests a link between exposure during pregnancy to har
By Nancy LapidOct 23 (Reuters) - Today we shine a light on a study that suggests just how misguided and potentially dangerous new US hepatitis B vaccination guidelines may
By Nancy LapidOct 21 (Reuters) - Today we report on the discovery of one of the likely causes of preterm labor and a potential pathway to prevent it. We also cover a study
(This is an excerpt of Health Rounds, winner of the 2026 Publishers Newsletter Award for Best Science Newsletter, where we present latest medical studies on Tuesdays and T
By Nancy LapidOct 15 (Reuters) - Hello Health Rounds readers! Today we highlight a study that found benefits of wearable glucose monitoring devices for all patients with di
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)By Nancy LapidOct 14 (Reuters) - Today we feature s
An early trial found optogenetic therapy restored object detection and localization abilities in some patients with retinitis pigmentosa. Separately, studies presented at ASTRO evaluated stereotactic radiotherapy for localized prostate cancer and brain metastases from small-cell lung cancer.
Researchers used artificial intelligence to develop heat-resistant lipid nanoparticles that kept mRNA vaccines stable at room temperature for up to a year. Separately, an AI model improved detection of heart transplant rejection, while laboratory studies examined how chronic tobacco smoke exposure contributes to lung cancer development.
An analysis of more than 30,000 appendicitis cases found appendectomy was associated with a lower risk of subsequent colorectal cancer than antibiotic treatment alone. Separately, studies linked GLP-1 use with nail and hair changes, while Kyverna's CAR T-cell therapy showed sustained benefits in stiff-person syndrome and myasthenia gravis.